• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Poised for phase 3, Galera's GC4419 wards off radiation side effects fiercebiotech
    August 21, 2018
    For many head and neck cancer patients who receive radiation therapy, side effects, such as oral mucositis, are a fact of life. This inflammatory condition cannot be prevented and can only be treated once it develops, but a synthetic enzyme from Galera Th

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service